ArticleInternational journal of pharmaceutics: X2026
A reduction-sensitive lipophilic dihydroartemisinin prodrug in a self-microemulsifying drug delivery system for treating breast cancer lung metastasis via intestinal lymphatic transport.
Bin Zheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.